Effectiveness of PENG Block Combined to LFCN Block on the Quality of Recovery After Total Hip Replacement (PENG)
Total Hip Replacement Surgery, Postoperative Pain
About this trial
This is an interventional treatment trial for Total Hip Replacement Surgery focused on measuring Regional anesthesia
Eligibility Criteria
Inclusion Criteria:
- Patients over 18 years old undergoing a total hip replacement surgery
Exclusion Criteria:
- Contraindication to regional anesthesia (allergy to local anesthetics, severe coagulopathy, infection in the designated area, pre-existing neuropathy in the obturator or femoral territory)
- Contraindication to spinal anesthesia
- Patient's refusal or inability to consent
- Opioid use on a regular basis pre-operatively
- Inability to communicate with medical team or research team
- Inability to understand the items of the multiple forms
Sites / Locations
- Centre Hospitalier de l'Université de Montréal (CHUM)Recruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
PENG and LFCN blocks with ropivacaine
PENG and LFCN blocks with saline solution
For the PENG block, and after negative aspiration, 20 ml of a solution of ropivacaine 0.5% with epinephrine 2.5 mcg/ml will be injected in 5 ml aliquots. Then, for the LFCN block, the lateral femoral cutaneous nerve will be localized, infero-medially to the antero-superior iliac spine, superficially to the sartorius muscle and 5 ml of the same solution will be injected with the same needle.
For the PENG block, and after negative aspiration, 20 ml of a saline solution will be injected in 5 ml aliquots. Then, for the LFCN block, the lateral femoral cutaneous nerve will be localized, infero-medially to the antero-superior iliac spine, superficially to the sartorius muscle and 5 ml of the same saline solution will be injected with the same needle.